Alfredo Santillan Gomez
Surgical Oncology · San Antonio, TXNPI 1124213400
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $94,038 of the $125,020 with a category attached, or 75.2%. Myriad Genetic Laboratories, Inc. accounts for 84.1% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2023 at $54,253 and has fallen 74.9% since, to $13,628 in 2025. Among surgical oncology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 157 payments — averaging $796.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Genetic Laboratories, Inc.$105K
- Merit Medical Systems Inc$17K
- Baxter Healthcare$497
- AbbVie$470
- AstraZeneca$268
- Johnson & Johnson$227
- plus $1K from 19 others
What the payments were for
- Consulting fees$23,64019%
- Speaking & faculty fees$94,03875%
- Travel & lodging$1,4001%
- Food & beverage$5,9295%
- Education$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 92 | $105,127 |
| Merit Medical Systems Inc | 11 | $17,256 |
| Baxter Healthcare | 10 | $497 |
| AbbVie | 4 | $470 |
| AstraZeneca | 3 | $268 |
| Johnson & Johnson(3 entities) | 7 | $227 |
| Endomagnetics Ltd | 1 | $160 |
| Nevro Corp. | 1 | $150 |
| Amgen | 2 | $140 |
| Lilly USA, LLC | 2 | $135 |
| Genentech USA, Inc. | 1 | $119 |
| Pulse Biosciences, Inc. | 1 | $92 |
| Novartis | 5 | $88 |
| KCI USA, Inc. | 1 | $46 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $36 |
| Caris MPI, Inc. | 2 | $35 |
| Tactile Systems Technology Inc | 2 | $33 |
| Molli Surgical (US) Inc | 1 | $29 |
| Seagen Inc. | 2 | $26 |
| Sanofi | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Pfizer | 1 | $13 |
| Merck | 1 | $12 |
| Trevena, Inc. | 1 | $12 |
| Intuitive Surgical | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- myRisk$79,435
- PreciseTumor$18,808
- Savi SCOUT$15,765
- BRACAnalysis$2,357
- GENESIGHT$1,700
- myChoice CDx$1,383
- TISSEEL$279
- BRACAnalysis CDx$219
- Magseed$160
- Magtrace$160
- Senza$150
- LYNPARZA$125
- AIRSUPRA$125
- DALVANCE$125
- VRAYLAR$125
- EVENITY$125
- UBRELVY$120
- Avastin$119
How this compares
$125,020 in reported general payments places this provider in the 95th percentile of 191 surgical oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 197 | $569 |
| Celecoxib | 169 | $463 |
| Doxycycline Hyclate | 29 | $420 |
| Levothyroxine Sodium | 66 | $402 |
| Anastrozole | 27 | $314 |
| Gabapentin | 184 | $230 |
| Calcitriol | 13 | $96 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in San Antonio
- Mio KitanoSan Antonio$32K
- Farbod MalekSan Antonio$16K
- Maryam ElmiSan Antonio$12K
- Allan WhiteSan Antonio$5K
- Alexander ParikhSan Antonio$5K
- Federico TozziSan Antonio$4K
- Allison DipasqualeDallas$272K
- Merrick RossHouston$216K
- John HardawayShenandoah$164K
- Steven CurleyTyler$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.